Business Description
CStone Pharmaceuticals
ISIN : KYG2588M1006
Compare
Compare
Traded in other countries / regions
02616.Hong KongPH4.GermanyCSPHF.USA IPO Date
2019-06-14Description
CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.83 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 0.8 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.14 | |||||
| Beneish M-Score | -1.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -30.1 | |||||
| 3-Year EBITDA Growth Rate | 42.7 | |||||
| 3-Year EPS without NRI Growth Rate | 30.2 | |||||
| 3-Year FCF Growth Rate | 4.8 | |||||
| 3-Year Book Growth Rate | -49.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.33 | |||||
| 9-Day RSI | 55.35 | |||||
| 14-Day RSI | 48 | |||||
| 6-1 Month Momentum % | -48.7 | |||||
| 12-1 Month Momentum % | -70.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | |||||
| Quick Ratio | 1.44 | |||||
| Cash Ratio | 1.21 | |||||
| Days Inventory | 108.77 | |||||
| Days Sales Outstanding | 94.39 | |||||
| Days Payable | 449.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | -6.51 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.58 | |||||
| Operating Margin % | -161.26 | |||||
| Net Margin % | -156.83 | |||||
| FCF Margin % | -41.85 | |||||
| ROE % | -166.38 | |||||
| ROA % | -45.68 | |||||
| ROIC % | -97.52 | |||||
| ROC (Joel Greenblatt) % | -411.87 | |||||
| ROCE % | -98.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.1 | |||||
| PB Ratio | 2.35 | |||||
| Price-to-Tangible-Book | 3.57 | |||||
| EV-to-EBIT | -0.52 | |||||
| EV-to-EBITDA | -0.53 | |||||
| EV-to-Revenue | 0.81 | |||||
| EV-to-FCF | -1.97 | |||||
| Price-to-Net-Current-Asset-Value | 10.7 | |||||
| Earnings Yield (Greenblatt) % | -192.87 | |||||
| FCF Yield % | -18.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CStone Pharmaceuticals Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 63.435 | ||
| EPS (TTM) (€) | -0.084 | ||
| Beta | 0.05 | ||
| Volatility % | 52.21 | ||
| 14-Day RSI | 48 | ||
| 14-Day ATR (€) | 0.00495 | ||
| 20-Day SMA (€) | 0.10144 | ||
| 12-1 Month Momentum % | -70.35 | ||
| 52-Week Range (€) | 0.092 - 0.366 | ||
| Shares Outstanding (Mil) | 1,275.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CStone Pharmaceuticals Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CStone Pharmaceuticals Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CStone Pharmaceuticals Frequently Asked Questions
What is CStone Pharmaceuticals(FRA:PH4)'s stock price today?
The current price of FRA:PH4 is €0.11. The 52 week high of FRA:PH4 is €0.37 and 52 week low is €0.09.
When is next earnings date of CStone Pharmaceuticals(FRA:PH4)?
The next earnings date of CStone Pharmaceuticals(FRA:PH4) is 2024-08-15 Est..
Does CStone Pharmaceuticals(FRA:PH4) pay dividends? If so, how much?
CStone Pharmaceuticals(FRA:PH4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers